FDA Approvals

Date Posted
Article Title
6/18/2010
Tasigna Approval Widened to Include Early Stages of Rare Leukemia

But users are at greater risk of heart disorder

6/17/2010
Jevtana Approved for Advanced Prostate Cancer

When disease continues to worsen after treatment with standard drug

6/2/2010
Prolia Approved for Post-Menopausal Women With Osteoporosis

Injectable drug given once every 6 months

5/25/2010
5/24/2010
Simplexa H1N1 Test Approved

Detects 'swine flu' infection

5/17/2010
Sprix Approved for Moderate-to-Severe Pain

A non-narcotic nasal spray

5/6/2010
New Hormonal Contraceptive Approved

Combines estrogen and progestin

5/3/2010
New Parasite Screening Test Approved

For donated blood, tissue and organs

4/29/2010
Provenge Approved for Advanced Prostate Cancer

Helps immune system combat the disease

4/28/2010
4/13/2010
Pancreaze Approved for Lack of Pancreatic Enzymes

200,000 in U.S. need such products

4/8/2010
First Generic Versions of Cozaar and Hyzaar Approved

Drugs to treat high blood pressure

4/6/2010
Tougher-to-Abuse Form of OxyContin Approved

These pills are harder to cut and dissolve, maker says

4/5/2010
3/31/2010
Asclera Approved to Treat Varicose Veins

Improves appearance of swollen or twisted blood vessels

3/26/2010
Zyclara Approved to Treat Pre-Cancerous Skin Condition

Some 10 million Americans have actinic keratoses

3/25/2010
Xifaxan Approved for People With Liver Disease

To treat disorder that affects brain function

3/18/2010
Carbaglu Approved for Rare Genetic Disorder

Causes elevated ammonia in blood

3/17/2010
Implanted Hearing System Approved

To treat senorineural hearing loss

3/12/2010
Pelvic Artery Stent Approved

Props open vessel that supplies blood to the legs